FACTANKER

US-Listed Biological Products, (No Diagnostic Substances) — EBITDA Margin Percentiles, FY 2022

Population: 61 US-listed companies (SIC 2836), fiscal year 2022; fiscal year ends 2022-06-30 to 2023-04-30.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile-587.2%
25th percentile-432.4%
Median-149.2%
75th percentile-31.1%
90th percentile36.0%
Mean-238.8%
Minimum-874.2%
Maximum133.6%
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2022 = fiscal years ending 2022-06-01 to 2023-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest EBITDA Margin percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2836/ebitda-margin/2022